Robert W. Baird Cuts Owens & Minor (NYSE:OMI) Price Target to $10.00

Owens & Minor (NYSE:OMI) had its price target lowered by equities research analysts at Robert W. Baird from $14.00 to $10.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird’s price objective would suggest a potential upside of 46.31% from the company’s previous close.

OMI has been the subject of a number of other research reports. Citigroup decreased their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Barclays decreased their target price on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 5th. Finally, UBS Group decreased their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Owens & Minor currently has an average rating of “Hold” and an average price target of $14.92.

Owens & Minor Trading Down 3.0 %

Shares of NYSE:OMI opened at $6.84 on Tuesday. Owens & Minor has a 12 month low of $6.07 and a 12 month high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The company’s fifty day simple moving average is $11.68 and its 200 day simple moving average is $13.35. The firm has a market cap of $527.04 million, a price-to-earnings ratio of -10.52, a PEG ratio of 0.20 and a beta of 0.48.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of OMI. FMR LLC boosted its holdings in shares of Owens & Minor by 0.8% during the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after buying an additional 90,862 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Owens & Minor by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 8,915,756 shares of the company’s stock worth $116,529,000 after buying an additional 107,092 shares during the period. Coliseum Capital Management LLC boosted its holdings in shares of Owens & Minor by 31.3% during the 4th quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company’s stock worth $62,553,000 after buying an additional 1,141,483 shares during the period. State Street Corp boosted its holdings in shares of Owens & Minor by 2.6% during the 3rd quarter. State Street Corp now owns 3,064,547 shares of the company’s stock worth $48,083,000 after buying an additional 78,985 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Owens & Minor by 13.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock worth $30,127,000 after buying an additional 276,807 shares during the period. Institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.